Peer-reviewedLicence not statedMolecular Pharmaceutics
Butyrate Regulates the Blood–Brain Barrier Transport and Intraendothelial Accumulation of Alzheimer’s Disease Amyloid-Beta Peptides
5 affiliations
- 1College of Pharmacy
- 2Department of Pharmaceutics and Brain Barriers Research Center
- 3University of Minnesota
- 4Department of Gastroenterology and Hepatology
- 5Mayo Clinic
Related
- The potato (Solanum tuberosum L.) transcription factor StPHR1 responds to low phosphate stress and regulates phosphorus accumulation
- Nuclear acetyl-CoA accumulation drives reversible RBP hyperacetylation and transcriptome-wide splicing shifts in age-equivalent Alzheimer's disease neurons
- The Alzheimer's Disease-associated gene CD2AP regulates permeability of endothelial cells and transendothelial migration of immune cells
- Zika virus infection induces a persistent accumulation of Alzheimer’s disease-like Tau phosphorylation in adult immunocompetent mice in association with memory and social behavior impairments
- Fragile X syndrome-linked mutations impair FMRP accumulation in neuronal transport granules
BibTeX
@article{veerareddy2026butyrate,
title = {{Butyrate Regulates the Blood–Brain Barrier Transport and Intraendothelial Accumulation of Alzheimer’s Disease Amyloid-Beta Peptides}},
author = {Vaishnavi Veerareddy and Zengtao Wang and Purna Kashyap and Karunya K. Kandimalla},
journal = {Molecular Pharmaceutics},
year = {2026},
month = may,
doi = {10.1021/acs.molpharmaceut.5c01594},
url = {https://doi.org/10.1101/2025.10.24.684335},
}
RIS
TY - JOUR
TI - Butyrate Regulates the Blood–Brain Barrier Transport and Intraendothelial Accumulation of Alzheimer’s Disease Amyloid-Beta Peptides
AU - Vaishnavi Veerareddy
AU - Zengtao Wang
AU - Purna Kashyap
AU - Karunya K. Kandimalla
PY - 2026
DA - 2026/05/21
JO - Molecular Pharmaceutics
DO - 10.1021/acs.molpharmaceut.5c01594
UR - https://doi.org/10.1101/2025.10.24.684335
SN - 1543-8384
SN - 1543-8392
ER -